THIO has gained its generic name and preclinical data on a different form of the cancer drug suggests it could improve ...

According to professional astrologer June of Saturn and Honey, “two people are astrologically compatible when their charts ...

A group of BTech students from Amity University, Lucknow, has developed an AI-based device named 'Mukta' that can detect oral ...

As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer ...

An indigenously developed gene therapy for specific blood cancers has shown a 73 per cent response rate among patients in ...

(CBS News) Vepdegestrant, a potential first-in-class PROTAC degrader, produced mixed results in a closely watched clinical ...

What do the stars have in store for you this week?

The scientists caution that, in some people, aspirin can have serious side-effects and clinical trials are underway to determine how to use it safely and effectively to prevent cancer spread ...

I-Mab (NASDAQ:IMAB) ADRs traded ~11% higher in the premarket after the biotech indicated a faster-than-expected advancement in its Phase 1b trial for its experimental gastric cancer therapy ...

Melatonin is produced by the pineal gland in our brains when darkness falls. It signals to our bodies that its time to wind down and prepare for sleep.

LONDON - Avacta Therapeutics (AIM: AVCT (LON:AVCT)), a developer of peptide drug conjugates for cancer treatment, has reported encouraging results from the Phase 1a dose escalation trial of its lead ...

One in 6 patients in phase 2 cancer trials received treatments that were eventually approved by the US Food and Drug Administration (FDA), a new analysis found. This proportion increased to 1 in 5 ...